Abstract

Advances in proteomic methodologies based on quantitative mass spectrometry are now transforming pharmacology and experimental biology more broadly. The present review will discuss several examples, based on work in the author's laboratory that focuses on delineating relationships between GPCR signaling and trafficking in the endocytic network. The examples highlighted correspond to those discussed in a talk presented at the 2019 EB/ASPET meeting, organized by Professor Joe Beavo to commemorate his receipt of the Julius Axelrod Award.

Significance Statement This is a review related to the EB2019 Axelrod Symposium.